Brexucabtagene autoleucel: a breakthrough in the treatment of mantle cell lymphoma. A Deshpande, Y Wang, J Munoz, P Jain Drugs of Today (Barcelona, Spain: 1998) 58 (6), 283-298, 2022 | 6 | 2022 |
Radiation and chimeric antigen receptor T-cell therapy in B-cell non-Hodgkin lymphomas A Deshpande, W Rule, A Rosenthal Current Treatment Options in Oncology 23 (1), 89-98, 2022 | 6 | 2022 |
Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First A Deshpande, J Munoz Therapeutics and Clinical Risk Management, 657-668, 2022 | 4 | 2022 |
PopInf: an approach for reproducibly visualizing and assigning population affiliation in genomic samples of uncertain origin AM Taravella Oill, AJ Deshpande, HM Natri, MA Wilson Journal of Computational Biology 28 (3), 296-303, 2021 | 4 | 2021 |
Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer AJ Deshpande, A Bhandarkar, WV Bobo, M Bydon, S Niazi, S McLaughlin The American Journal of Surgery 226 (1), 4-10, 2023 | 2 | 2023 |
Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver A Deshpande, J Munoz, K Kelemen, V Dabak, A Hanbali, R Kurzrock Journal of Immunotherapy and Precision Oncology 6 (1), 56-58, 2023 | 1 | 2023 |
Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies A Deshpande, J Munoz Frontiers in Oncology 12, 948513, 2022 | 1 | 2022 |
Analysis of gender-based authorship trends in leading pain-medicine journals over 10 years N Strand, M Kraus, C Pougnier, A Keim, A Deshpande, J Maloney Health Psychology Research 10 (4), 2022 | 1 | 2022 |
Isoform Variation across Triple Negative Breast Cancer and Prostate Cancer AJ Deshpande | | 2019 |